Ebit változás Dátum
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.8B 254M 2023-12
Biogen USD 512M 226.7M 2023-12
BioMarin Pharmaceutical USD 28.22M 2.56M 2023-12
Bluebird Bio USD -84729000 568K 2023-09
Daiichi Sankyo JPY 51.03B 7B 2023-09
Esperion Therapeutics USD -27533000 9.52M 2023-09
Exelixis USD -17583000 95.43M 2023-09
Gilead Sciences USD 2.15B 475M 2023-12
Incyte USD 205.23M 10.1M 2023-12
Moderna USD 6M 2.02B 2023-12
Pfizer USD -125000000 2.34B 2023-12
PTC Therapeutics USD 8.02M 126.18M 2023-12
Regeneron Pharmaceuticals USD 1B 208.1M 2023-12
Roche Holding CHF 10.6B 2.12B 2023-06
Sarepta Therapeutics USD -20842000 112.68M 2023-09
Takeda JPY -49342000000 217.91B 2023-09
TG Therapeutics USD -12485000 127.27M 2023-12
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vanda Pharmaceuticals USD -2867000 4.87M 2023-06
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Puma Biotechnology - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.